Ionis Pharmaceuticals Inc
IONS· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $57.08M | $38.09M | $47.34M | $24.82M |
| Net Income | -$12.08M | -$10.13M | — | -$17.89M |
| EPS Diluted | -$0.10 |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| -$0.09 |
| -$0.01 |
| -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.